%0 Journal Article
%A Cañete, Adela
%A Peris-Bonet, Rafael
%A Capocaccia, Riccardo
%A Pardo-Romaguera, Elena
%A Segura, Vanessa
%A Muñoz-López, Ana
%A Fernández-Teijeiro, Ana
%A Galceran-Padros, Jaume
%A Gatta, Gemma
%A Spanish Neuroblastoma Linkage Working Group (SpNbLinkWG)
%T Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries - A study by the Joint Action on Rare Cancers.
%D 2022
%U http://hdl.handle.net/10668/22069
%X Linkage between clinical databases and population-based cancer registries may serve to evaluate European Reference Networks' (ERNs) activity, by monitoring the proportion of patients benefiting from these and their impact on survival at a population level. To test this, a study targeting neuroblastoma (Nb) was conducted in Spain by the European Joint Action on Rare Cancers. Subjects: Nb cases, incident 1999-2017, aged  National completeness estimates for RETI and NbCDB were 91% and 72% respectively, using the Spanish RPBCRs on International Incidence of Childhood Cancer (https://iicc.iarc.fr/) as reference. RPBCRs' specific contribution was 1.6%. Linkage required manual crossover in 54% of the semiautomatic matches. Five-year survival was 74% (0-14 years) and 90% (0-18 months). All three databases were incomplete as regards Spain as a whole and should therefore be combined to achieve full childhood cancer registration. A unique personal patient identifier could facilitate such linkage. Most children have access to Nb clinical trials. Consolidated interconnections between the national registry and clinical registries (including ERNs and paediatric oncology clinical groups) should be established to evaluate outcomes.
%K Cancer registry
%K Childhood cancer
%K Clinical registry
%K Completeness
%K European Reference Network
%K Incidence
%K Joint Action on Rare Cancers
%K Neuroblastoma
%K Record linkage
%K Survival
%~